Yahoo Finance13h
Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook
Recognized as innovative biopharma developing a potentially safer and superior anticoagulant for patients with implanted cardiac devices and rare cardiovascular conditions PONTE VEDRA, Fla., Nov. 19, ...
Patients taking edoxoban after heart valve surgery found to have lower risk of stroke, blood clots
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...
Endocrinology Advisor1d
Oral Anticoagulant Prescribing Patterns Differ Between Rural and Urban Areas
DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.
Talphera’s Promising Prospects: Buy Rating Affirmed Amidst Strategic Advancements in Anticoagulant Development
Maxim Group analyst Naz Rahman has reiterated their bullish stance on TLPH stock, giving a Buy rating on November 14. Naz Rahman has given his ...
HealthDay on MSN8h
Adding Blood Thinners to A-fib Treatment Won't Prevent Strokes, Help Cognition
People using blood thinners to control their heart rhythm shouldn't expect the medications to head off thinking declines as ...
Daily1d
Edoxaban as effective as Warfarin After Bioprosthetic Valve Surgery: ENBALV
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...
HealthDay on MSN1d
Bleeding Risk Increased With NSAID Use for VTE Patients Receiving Anticoagulants
Patients with venous thromboembolism (VTE) initiating oral anticoagulants have an increased risk for bleeding when usi ...
Medpage Today on MSN2d
Big Blow to Anticoagulation Strategy Against Afib-Related Cognition Problems
CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the ...
News Medical on MSN1d
Edoxaban proves effective in preventing blood clots, stroke after heart valve surgery
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...
Medpage Today on MSN1d
Left Atrial Appendage Closure Reduced Bleeding After Afib Ablation
Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...
TAHO Pharmaceuticals Initiates U.S. Phase III Clinical Trial of TAH3311 Antithrombotic Oral Dissolving Film, Dosing First Subjects
TAHO Pharmaceuticals Ltd. announced the dosing of the first subjects in its U.S. Phase III clinical trial for its lead product, TAH3311, an innovative antithrombotic oral dissolving film (ODF). In ...
Boston Scientific’s WATCHMAN FLX: Poised for Growth with New Trial Results and Reimbursement Code
Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on BSX stock, giving a Buy rating yesterday.Don't Miss our Black ...